Differences in clinical features of cluster headache between drinkers and nondrinkers in Japan
Autoři:
Noboru Imai aff001; Eiji Kitamura aff002
Působiště autorů:
Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Shizuoka, Japan
aff001; Department of Neurology, Kitasato University, Sagamihara, Kanagawa, Japan
aff002
Vyšlo v časopise:
PLoS ONE 14(11)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0224407
Souhrn
Objective
Alcohol has been recognized as the main trigger for a cluster headache attack, but clinical features to distinguish between cluster headache in drinkers and nondrinkers are unclear. Thus, the present study aimed to investigate the differences in clinical features of cluster headache between drinkers and nondrinkers.
Methods
This retrospective, observational study compared the clinical features of cluster headache between drinkers and nondrinkers among patients who were diagnosed with cluster headache between November 2004 and April 2018 at the Japanese Red Cross Shizuoka Hospital. Demographic and clinical data were collected from medical records and/or by patient interview.
Results
Of 131 patients, 98 (75%) were drinkers, and 33 (25%) were nondrinkers. Compared with nondrinkers, drinkers had significantly more frequent conjunctival injection (43% vs. 21%, p = 0.037) but significantly less frequent nasal congestion (31% vs. 52%, p = 0.0037), vomiting (11% vs. 30%, p = 0.014), and photophobia (29% vs. 45%, p = 0.008).
Conclusion
Among individuals with cluster headache, the frequencies of conjunctival injection, nasal congestion, vomiting, and photophobia were different between drinkers and nondrinkers. These results suggested that drinking might influence the responses of the cranial autonomic reflex with respect to conjunctival injection or nasal congestion.
Klíčová slova:
Body Mass Index – Alcohol consumption – Headaches – Migraine – Reflexes – Nausea – Vomiting – Cluster headache
Zdroje
1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629–808.
2. Levi R, Edman GV, Ekbom K, Waldenlind E. Episodic cluster headache II: high tobacco and alcohol consumption in males. Headache. 1992; 32: 184–187. doi: 10.1111/j.1526-4610.1992.hed3204184.x 1582837
3. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002; 58: 354–361. doi: 10.1212/wnl.58.3.354 11839832
4. Schürks M, Kurth T, de Jesus J, Jonjic M, Rosskopf D, Diener HC. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006; 46: 1246–1254. doi: 10.1111/j.1526-4610.2006.00534.x 16942468
5. Donnet A, Lanteri-Minet M, Guegan-Massardier E, Mick G, Fabre N, Geraud G, et al. Chronic cluster headache: a French clinical descriptive study. J Neurol Neurosurg Psychiatry. 2007; 78: 1354–1358. doi: 10.1136/jnnp.2006.112037 17442761
6. Rainero I, Rubino E, Gallone S, Fenoglio P, Negro E, De Martino P, et al. Cluster headache is associated with the alcohol dehydrogenase 4 (ADH4) gene. Headache. 2010; 50: 92–98. doi: 10.1111/j.1526-4610.2009.01569.x 19925625
7. Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache. 2012; 52: 99–113. doi: 10.1111/j.1526-4610.2011.02028.x 22077141
8. Steinberg A, Fourier C, Ran C, Waldenlind E, Sjostrand C, Belin AC. Cluster headache—clinical pattern and a new severity scale in a Swedish cohort. Cephalalgia. 2018; 38: 1286–1295. doi: 10.1177/0333102417731773 28906127
9. Lund N, Petersen A, Snoer A, Jensen RH, Barloese M. Cluster headache is associated with unhealthy lifestyle and lifestyle-related comorbid diseases: Results from the Danish Cluster Headache Survey. Cephalalgia. 2019; 39: 254–236. doi: 10.1177/0333102418784751 29933701
10. Lin KH, Wang PJ, Fuh JL, Lu SR, Chung CT, Tsou HK, et al. Cluster headache in the Taiwanese—a clinic-based study. Cephalalgia. 2004; 24: 631–638. doi: 10.1111/j.1468-2982.2003.00721.x 15265051
11. Dong Z, Di H, Dai W, Pan M, Pan M, Li Z, Liang J, et al. Clinical profile of cluster headaches in China—a clinic-based study. J Headache Pain. 2013; 14: 27. doi: 10.1186/1129-2377-14-27 23574884
12. Imai N, Yagi N, Kuroda R, Konishi T, Serizawa M, Kobari M. Clinical profile of cluster headaches in Japan: low prevalence of chronic cluster headache, and uncoupling of sense and behavior of restlessness. Cephalalgia. 2011; 31: 628–633. doi: 10.1177/0333102410391486 21278239
13. Ministry of Health, Labour and Welfare, Japan. Basic Plan for Promotion of Measures against Alcohol-related Harm. 2019;6: 14. Available from: https://www.mhlw.go.jp/file/06-Seisakujouhou-12200000-Shakaiengokyokushougaihokenfukushibu/keikaku_2.pdf
14. Manzoni GC. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia. 1999; 19: 88–94. doi: 10.1046/j.1468-2982.1999.019002088.x 10214533
15. May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet. 2005; 366: 843–855. doi: 10.1016/S0140-6736(05)67217-0 16139660
16. Taga A, Russo M, Manzoni GC, Torelli P. Cluster headache with accompanying migraine-like features: a possible clinical phenotype. Headache. 2017; 57: 290–297. doi: 10.1111/head.12971 27861832
Článok vyšiel v časopise
PLOS One
2019 Číslo 11
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Je Fuchsova endotelová dystrofie rohovky neurodegenerativní onemocnění?
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations
- A 3’ UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction
- A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling
- Molecular validation of clinical Pantoea isolates identified by MALDI-TOF